CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-19 | HOFFMAN ROBERT CFO & SVP, Finance | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-12-15 | HOFFMAN ROBERT CFO & SVP, Finance | Grant or award · Employee Stock Option (Right to Buy) | +71,000 | 71,000 | ||
| 2018-07-02 | HOFFMAN ROBERT CFO & SVP, Finance | Exercise or conversion | +30,000 | $15.30 | $459K | 31,280 |
| 2018-07-02 | HOFFMAN ROBERT CFO & SVP, Finance | Sale | −28,940 | $38.15 | $1.1M | 2,340 |
| 2018-07-02 | HOFFMAN ROBERT CFO & SVP, Finance | Sale | −1,060 | $38.80 | $41K | 1,280 |
| 2018-07-02 | HOFFMAN ROBERT CFO & SVP, Finance | Exercise or conversion · Employee Stock Option (Right to Buy) | −30,000 | 100,000 | ||
| 2018-04-30 | HOFFMAN ROBERT CFO & SVP, Finance | Other acquisition | +744 | $13.22 | $10K | 1,280 |
| 2017-12-18 | HOFFMAN ROBERT CFO & SVP, Finance | Grant or award · Employee Stock Option (Right to Buy) | +56,667 | 56,667 | ||
| 2017-10-31 | HOFFMAN ROBERT CFO & SVP, Finance | Other acquisition | +536 | $13.05 | $7K | 536 |
| 2017-04-24 | HOFFMAN ROBERT CFO & SVP, Finance | Grant or award · Employee Stock Option (Right to Buy) | +130,000 | 130,000 |
Page 1 of 1 · 10 trades